BHLHE40 and Parkinson disease: In a cohort of 17 PD patients BMAL1, BMAL2, DEC1, CLOCK and PER1 expression were evaluated during the night, at four time points, from 21 h to 9 h, and compared between PD patients and a healthy control group (sex and age matched) [48,49].